MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cam4.4651

Медицинская библиотека · Cancer medicine · 2022

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.

Yang Yilan, Zhao Xu, Wang Xuanyi, Jin Kairui, Luo Jurui, Yang Zhaozhi, Mei Xin, Ma Jinli, Shao Zhimin, Zhang Zhen, Chen Xingxing, Guo Xiaomao, Yu Xiaoli

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: Currently, the prognostic value of molecular subtypes in ductal carcinoma in situ (DCIS) remains unclear. In this study, we explored whether molecular subtypes could predict second breast events (SBEs) in patients after breast-conserving surgery (BCS).

METHODS

From January 2008 to December 2016, 291 DCIS patients treated with BCS were retrospectively analyzed. Patients were classified into four molecular subtypes: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) overexpression, and triple-negative breast cancer (TNBC). The SBE incidence was calculated by the competing risk model and compared by Gray's test. The disease-free survival rates were estimated by the Kaplan-Meier method and compared by the log-rank test. Prognostic factors were evaluated by univariate and multivariate COX proportional hazards regression model.

RESULTS

With a median follow-up of 66 months, 12 SBEs were identified. The 5-year overall SBE incidence of luminal A, luminal B, HER2 overexpression, and TNBC was 2.18%, 4.25%, 15.15%, and 0.00%, respectively. In the univariate analysis, the HER2 overexpression subtype was the predictor of overall (p = 0.005), in situ (p = 0.004), and ipsilateral SBEs (p = 0.008). Patients with endocrine therapy were less likely to develop in situ SBEs (p = 0.039). Additionally, patients with closed (<2 mm) or involved margins were related to a higher risk of contralateral SBEs (p = 0.029). In the multivariate analysis, the HER2 overexpression subtype remained of prognostic values for overall (p = 0.006), in situ (p = 0.029), and ipsilateral SBEs (p = 0.012).

CONCLUSIONS

The molecular subtype, especially the HER2 overexpression subtype, was the independent prognostic factor for DCIS patients who underwent BCS.

Для цитирования: Yang Yilan, Zhao Xu, Wang Xuanyi, Jin Kairui, Luo Jurui, Yang Zhaozhi, Mei Xin, Ma Jinli, Shao Zhimin, Zhang Zhen, Chen Xingxing, Guo Xiaomao, Yu Xiaoli. Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.. Cancer medicine. 2022. DOI: 10.1002/cam4.4651.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.